Call for Workshop: 5th World Congress on Vaccine and Immunology
November 06-07, 2023 | Tokyo, Japan
5th World Congress on Vaccine and Immunology
https://vaccineimmunology.conferenceseries.com/
Vaccine Immunology 2023 is going to welcome participants from all over the world to attain the Vaccine immunology conference, which is going to be held in Tokyo, Japan during November 06-07, 2023 based on the theme Expanding New Horizons in Advances of Vaccine Immunology. This gathering will concentrate on existing and most recent developments in every aspect of vaccine and immunology research. On behalf of all the Organizing Committee Members, we invite all the Vaccine researchers & top immunologists, industrialists, young scientists as well as students and corporate kings to join and to give great success from different regions of vaccines, vaccinations, immunology, and its uses.
WHY ATTEND?
Vaccine and immunology conference 2023 is aimed at the World's leading Medical Conference. The two days event on the same will host many Scientific and technical sessions and sub-sessions on leading and latest research transformations related to the field of vaccine & immunology, covering the globe. The attendees can find exclusive sessions and panel discussions on the latest innovations in Vaccine and immunology by:
- Best platform for international business and Networking opportunities
- Keynote forums by eminent Professors, Engineers
- Novel techniques to benefit your research and innovation
- Open Innovation Challenges
- Meet the editors of refereed journals, Society and Association members across the world
- Poster presentations by Young Researchers on Immunology
- Excellent platform to showcase the latest innovation and concepts in the vaccination field
- Lectures from prominent speakers
Target Audience:
- Immunologists
- Microbiologists
- Virologists
- Physicians
- Rheumatologists
- Clinical Immunologists
- Biotechnologists
- Pulmonologists
- Pathologists
- Allergists
- Immunology professionals
- Pediatricians
- Various Societies and their members
- Research Scholars
- Institutes-Medical Schools Students
- University Professors
- Manufacturing Medical Devices Companies
- Laboratory technicians
- Business Entrepreneurs
- Companies producing vaccines, GMOs, and allergy therapeutics
Vaccine Immunology Market Analysis
The Vaccine and immunology conference welcomes attendees, presenters, and exhibitors from all over the world. We are delighted to invite all of you to participate and register for the "5th world Congress on Vaccine and Immunology"
The organizing committee is preparing for an exciting and informative conference program comprising plenary lectures, symposia, workshops on a variety of topics, poster presentations, and various programs for participants from all over the world. We invite you to join us at the "5th world Congress on Vaccine and Immunology" where you will be sure to have a meaningful experience with academics from around the world. All members of the organizing committee look forward to meeting you in Toronto, Canada.
Vaccine Market Overview-2027:
The global vaccine market size was $ 32,462 million in 2019 and is expected to reach $ 54,150 million by 2027, registering a CAGR of 6.6% from 2020 to 2027.
Vaccines, also called immunizations, inject a weakened form of a disease into a person so that the body begins to produce antibodies or immunity to the disease. Effective vaccination has eradicated a number of diseases, such as polio and smallpox, with high death rates. Vaccinations play a crucial role in maintaining the sustainable health of people in different countries; therefore, they are used in various regional disease prevention strategies. The demand for vaccines has increased in recent years, due to the increasing incidence of infectious viral and bacterial diseases. Vaccinations are mainly given to people of different age groups, which strengthen their immune systems throughout life and provide protection against different types of infectious diseases.
Due to the COVID-19 pandemic, the majority of healthcare, pharmaceutical, and biotech organizations have focused on diagnostic kits, wearable safety devices, and treatment vaccines and drugs for the novel coronavirus. Most major companies are focused on finding a breakthrough vaccine against the Novel coronavirus. In addition, healthcare professionals are engaged in the provision of services related to COVID-19. As a result, other segments of health care must cope with neglect. Additionally, pharmaceutical companies are prioritizing the research and development of COVID-19-related diagnostics, treatments, health technologies, and vaccines, as well as the potential of existing treatments. All of these factors are also expected to impact the global vaccine market in the future.
The increased investment in the development of new vaccines is expected to boost the global vaccine market in the coming years. For example, researchers at Scripps Research Florida have successfully developed a non-traditional vaccine to defeat the SIVmac239 viral strain dubbed "the death star." The unconventional vaccine developed by the researchers provides long-lasting protection to uninfected people against multiple forms of HIV driving demand for the vaccine. In addition, the increasing incidence of various infectious diseases and the growing awareness of early disease diagnosis and prevention are driving the demand for protective vaccines; thus, stimulating the growth of the market.
Several efforts by organizations, including UNICEF, have increased the uptake of the vaccine over the years. The Pan American Health Organization's (PAHO) revolving fund and the influence of UNICEF's supply division make it possible to purchase vaccines at lower prices for various countries. Each year, PAHO and UNICEF purchase vaccines for nearly 40 states and about 100 countries, respectively; which has a positive impact on the adoption rate.
Vaccination helps prevent nearly 2 to 3 million deaths from various diseases, including influenza, tetanus, diphtheria, measles, whooping cough, and others. In addition, according to the WHO, more than 1.5 million deaths can be prevented by improving global immunization coverage. In 2018, around 116.3 million children under one year of age received three doses of the diphtheria-tetanus-pertussis (DTP3) vaccine worldwide. As vaccine delivery increases, vaccine activity will expand dramatically over the next few years.
Limited vaccination coverage coupled with prohibitive costs of transporting and storing vaccines will negatively impact the expansion of the industry to some extent in the near future. In addition, strict government regulations for product approval will prolong the process of introducing new products to the market; which is slowing the growth of the vaccine market.
For more details Contact Us:
What's App: +44-7723-584563